Alex Herrera, MD, associate professor of medicine and lymphoma “guru” at the City of Hope Comprehensive Cancer Center, joins the show on the last day of the ASCO Annual Meeting after being on stage for his Plenary session. Dr. Herrera shares the remarkable, resilient story of his family life, upbringing, life-altering injury, and improbable journey from playing baseball in Miami to a leadership role at City of Hope. Captivating, inspiring, gut-wrenching, and uplifting, Dr. Herrera’s account is truly worthy of your attention.
Read Dr. Herrera’s story in The ASCO Post: ascopost.com/issues/december-25…e-at-city-of-hope/
Dr. Simrit Parmar, founder of Cellenkos, joins the show to discuss her journey from the lab to the biotech startup world, detailing the inspiration behind launching her company, the challenges of securing funding, and the resilience required to overcome rejections. She shares insights into Cellenkos’ lead product, its progress toward market approval, and the rigorous
Carol Rausch—a healthcare professional, cancer researcher, and former patient with lymphoma—shares how her journey from researcher to patient transformed her understanding of medical language. She discusses the impact of word choice on patients, why certain battle and war metaphors can be harmful, and how language used in clinical settings differs from what resonates with those
Drs. David Braun and Toni Choueiri join to discuss a groundbreaking Nature study on a personalized neoantigen vaccine for adjuvant renal cell carcinoma. They explore the inspiration behind the trial, how the vaccine was developed and administered, and its safety profile. The conversation also covers patient outcomes after 3-4 years, including immune responses and disease
